This key provides the non-specialist with reference material to help recognise an invasive mosquito species and gives details on the morphology to help with verification.
The ECDC HIV Platform Tool is a new end-user application that uses statistical and mathematical methods to calculate adjusted estimates from HIV surveillance data, considering the issues of missing data and reporting delay and employing modelling techniques.
The HIV estimates accuracy tool is an end user application that uses statistical methods to calculate adjusted estimates from HIV surveillance data taking into account the issues of missing data and reporting delay.
This guidance aims to provide EU/EEA countries with an evidence-based framework to help develop, implement, monitor and evaluate their own national HBV, HCV and HIV testing guidelines and programmes.
The HIV Modelling Tool is an application which uses evidence-based methods to calculate HIV incidence in a given population. It helps to understand local HIV epidemics by providing better estimates based on surveillance data.
This evidence-based guidance is designed to inform the development, monitoring and evaluation of national strategies and programmes in countries in Europe in order to reduce and prevent infections among people who inject drugs.
The content of this joint guidance was developed by the European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) with the support of a technical advisory group composed of policy makers, service providers, civil society representatives and preventative health experts from throughout the EU/EEA.
In the closed cabin environment of modern airplanes, passengers are frequently exposed to various infectious diseases. This report looks at 12 infectious diseases and, by systematically evaluating literature on on-board transmission, attempts to assess the risk of infection via air circulation in airplanes.
These guidelines are complemented by operational guidelines in relation to tuberculosis, new emerging airborne diseases (e.g. SARS) and meningococcal infections.